Hikma’s Injectables Business Expands As It Completes Custopharm Acquisition

Completion Of $425m Deal Comes Shortly After FTC Approved The Transaction

Complete Word Jigsaw Pieces
Hikma has now completed its deal to acquire Custopharm • Source: Cagkan Sayin / Alamy Stock Photo

More from Deals

More from Business